Norges Bank Portfolio holdings
Norges Bank, established in 1816 and headquartered in Oslo, Norway, serves as the central bank of Norway, responsible for monetary policy, issuing the Norwegian krone, and maintaining financial stability. Beyond its traditional central banking role, it oversees the management of the Government Pension Fund Global (often called the Norwegian Oil Fund), one of the world’s largest sovereign wealth funds, valued at over $1 trillion, which invests Norway’s oil and gas revenues in global equities, bonds, and real estate. The fund’s investment arm, Norges Bank Investment Management (NBIM), operates independently to ensure long-term wealth preservation for future generations, emphasizing sustainable and ethical investing practices. With its dual role, Norges Bank uniquely blends central banking duties with stewardship of a massive global investment portfolio.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$864M |
| 2 |
T-Mobile US
TMUS
|
+$580M |
| 3 |
Meta Platforms (Facebook)
META
|
+$367M |
| 4 |
AbbVie
ABBV
|
+$348M |
| 5 |
Blackrock
BLK
|
+$335M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$692M |
| 2 |
RTN
Raytheon Company
RTN
|
+$368M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$279M |
| 4 |
Visa
V
|
+$237M |
| 5 |
Intel
INTC
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.84% |
| 2 | Healthcare | 13.58% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 13.35% |
| 5 | Communication Services | 10.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Tredegar Corp
TG
$265M
| $5.58M | ﹤0.01% |
362,139
| – | – |
|
|
AEGN
1852
DELISTED
Aegion Corp
AEGN
| $5.53M | ﹤0.01% |
348,132
| – | – |
|
|
VIE
1853
DELISTED
Viela Bio, Inc. Common Stock
VIE
| $5.39M | ﹤0.01% |
+124,345
| New | +$5.63M |
|
1854
Zymeworks
ZYME
$1.61B
| $5.33M | ﹤0.01% |
147,914
+112,622
| +319% | +$4.15M |
|
|
STFC
1855
DELISTED
State Auto Financial Corp
STFC
| $5.33M | ﹤0.01% |
298,493
-48,638
| -14% | -$1.04M |
|
1856
Invesco Mortgage Capital
IVR
$759M
| $5.31M | ﹤0.01% |
141,968
-71,039
| -33% | -$2.44M |
|
|
API
1857
Agora
API
$337M
| $5.3M | ﹤0.01% |
+120,000
| New | +$5.67M |
|
|
JKS
1858
JinkoSolar
JKS
$777M
| $5.2M | ﹤0.01% |
293,575
-120,390
| -29% | -$1.93M |
|
|
OCFT
1859
DELISTED
OneConnect Financial Technology
OCFT
| $5.14M | ﹤0.01% |
28,125
-91,875
| -77% | -$12.3M |
|
1860
Rhythm Pharmaceuticals
RYTM
$6.81B
| $5.13M | ﹤0.01% |
230,195
| – | – |
|
|
MRC
1861
DELISTED
MRC Global
MRC
| $5.11M | ﹤0.01% |
864,458
-49,686
| -5% | -$258K |
|
1862
National Presto Industries
NPK
$870M
| $5.1M | ﹤0.01% |
58,332
+35,790
| +159% | +$3.04M |
|
1863
Amneal Pharmaceuticals
AMRX
$5.85B
| $5.08M | ﹤0.01% |
1,068,255
-59,249
| -5% | -$244K |
|
|
CEL
1864
DELISTED
Cellcom Israel, Ltd.
CEL
| $5.03M | ﹤0.01% |
1,279,671
| – | – |
|
|
BRFS
1865
DELISTED
BRF SA
BRFS
| $4.94M | ﹤0.01% |
1,243,370
| – | – |
|
1866
Inspire Medical Systems
INSP
$1.45B
| $4.91M | ﹤0.01% |
56,462
-92,830
| -62% | -$7.14M |
|
1867
Cytokinetics
CYTK
$10.5B
| $4.88M | ﹤0.01% |
+207,200
| New | +$3.89M |
|
|
PRSU
1868
Pursuit Attractions and Hospitality Inc
PRSU
$1.39B
| $4.87M | ﹤0.01% |
256,173
-127,087
| -33% | -$2.57M |
|
1869
Kosmos Energy
KOS
$1.6B
| $4.82M | ﹤0.01% |
2,904,273
+847,132
| +41% | +$1.36M |
|
|
VAPO
1870
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $4.81M | ﹤0.01% |
+14,663
| New | +$3.09M |
|
1871
Ceragon Networks
CRNT
$197M
| $4.76M | ﹤0.01% |
2,212,539
| – | – |
|
1872
Liberty Latin America Class A
LILA
$1.64B
| $4.68M | ﹤0.01% |
752,184
| – | – |
|
1873
Evolent Health
EVH
$348M
| $4.66M | ﹤0.01% |
654,982
+451,472
| +222% | +$3.02M |
|
1874
Vermilion Energy
VET
$1.82B
| $4.65M | ﹤0.01% |
1,045,904
-405,261
| -28% | -$1.91M |
|
1875
Forrester Research
FORR
$223M
| $4.63M | ﹤0.01% |
144,395
-82,372
| -36% | -$2.61M |
|
Similar funds
Norges Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Norges Bank held 2,120 positions worth $347B, up 24% from $281B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Norges Bank's Q2 2020 filing shows 74 new, 993 increased, 738 reduced and 44 closed positions. Its largest new stake was Nikola Corporation Common Stock: 333,333 shares worth $675M. The largest sale was Allergan plc, an estimated $692M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Norges Bank's largest Q2 2020 buy was Nikola Corporation Common Stock: 333,333 shares worth $675M.
- Norges Bank added most to Walmart Inc in Q2 2020, an estimated $864M increase.
- Norges Bank's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $279M.
- Norges Bank fully exited Allergan plc in Q2 2020, selling an estimated $692M.
- Norges Bank's ten largest holdings make up 22% of its $347B portfolio in Q2 2020.
- Norges Bank opened 74 new positions and closed 44 in Q2 2020.
- Norges Bank's portfolio value rose 24% quarter-over-quarter to $347B.
Based on Norges Bank's 13F filing for Q2 2020, filed 7 Aug 2020.